| Literature DB >> 25688759 |
Renjun Zhu, Adriana Blazeski, Ellen Poon, Kevin D Costa, Leslie Tung, Kenneth R Boheler.
Abstract
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) are the most promising source of cardiomyocytes (CMs) for experimental and clinical applications, but their use is largely limited by a structurally and functionally immature phenotype that most closely resembles embryonic or fetal heart cells. The application of physical stimuli to influence hPSC-CMs through mechanical and bioelectrical transduction offers a powerful strategy for promoting more developmentally mature CMs. Here we summarize the major events associated with in vivo heart maturation and structural development. We then review the developmental state of in vitro derived hPSC-CMs, while focusing on physical (electrical and mechanical) stimuli and contributory (metabolic and hypertrophic) factors that are actively involved in structural and functional adaptations of hPSC-CMs. Finally, we highlight areas for possible future investigation that should provide a better understanding of how physical stimuli may promote in vitro development and lead to mechanistic insights. Advances in the use of physical stimuli to promote developmental maturation will be required to overcome current limitations and significantly advance research of hPSC-CMs for cardiac disease modeling, in vitro drug screening, cardiotoxicity analysis and therapeutic applications.Entities:
Mesh:
Year: 2014 PMID: 25688759 PMCID: PMC4396914 DOI: 10.1186/scrt507
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Figure 1Schematic diagram illustrating developmental factors that potentially impact the maturation process from human pluripotent stem cell (hPSC)-derived cardiomyocytes to an adult-like phenotype with highly organized sarcomeres and intercellular junctions. This review focuses on physical developmental cues from electrical stimulation and mechanical loading, and also mentions factors including genetics, supporting cells and substrate, metabolism, and both circulating and membrane bound signaling molecules.
Figure 2Representative images of hPSC and hPSC-CM. (A) Representative images of human pluripotent stem cells (hPSCs) (left), a monolayer culture of hPSC-derived cardiomyocytes (hPSC-CMs; unstained, middle), and dissociated and re-plated human embryonic stem cell-derived cardiomyocytes immunostained with antibodies against cardiac troponin T (TNNT2; right) [139]. (B) Cardiac troponin I (TNNI3) immunostaining of a monolayer culture of human induced pluripotent stem cell-derived cardiomyocytes at day 29 of differentiation showing random patterns of striations. (C) Immunostaining of a three-dimensional tissue strip with well-aligned troponin-stained hPSC-CMs. Green, TNNT2 labeling (A, C), TNNI3 labeling (B); blue, DAPI labeling.
Summary of methods and relative maturation states of derived cardiomyocytes
| Study | Method of differentiation | Maturation state achieved and finding |
|---|---|---|
|
| Monolayer culture | High purity hESC- and hiPSC-derived CMs |
|
| Suspension EB | Expression level of genes encoding structural and force-generating proteins was comparable to fetal heart CMs |
|
| Suspension EB | Presence of functional gap junctions |
|
| Suspension EB | Electrical field stimulation increased expression of cardiac-specific genes |
| Stimulation promoted a ventricular-like phenotype | ||
| Stimulation improved calcium handling | ||
|
| Suspension EB | Mitochondrial oxidative metabolism is required for differentiation into a functional cardiac phenotype |
|
| Suspension EB | Showed active role for protein kinase signaling in hESC-CM growth and hypertrophy |
|
| Suspension EB | Ultrastructural features of early and immature phenotype: |
| Myofibrils with sarcomeric pattern | ||
| Large glycogen deposits, | ||
| Lipid droplets | ||
| Ca2+ release units detected on the sarcoplasmic reticulum | ||
| Underdeveloped intercalated disks | ||
| Spatial location of cells within EBs can affect their phenotype | ||
| Cx43 expression not detected | ||
|
| Suspension EB | Including long-term culture (up to 180 days) |
| Myofibrils became tightly packed and formed parallel arrays | ||
| Appearance of mature Z-, A-, H-, and I-bands | ||
| M-bands detected in 360-day-old EBs | ||
|
| Suspension EB | hESC-CM tissue engraftment |
| Structural and electromechanical connections with NRVMs | ||
| Rate-responsive biological pacemaker | ||
|
| Cardiac bodies | Formation of bioartificial cardiac tissue and use of defined animal-free matrix |
|
| Suspension EB | Induction of adult-like metabolism is critical for establishing disease onset in patient-specific iPSCs |
|
| Suspension EB | Co-culture with non-cardiomyocytes rescued the arrest of electrophysiological maturation observed following hESC-CM isolation from EBs in early cultures |
| Purified CMs with a-MHC-PacR | ||
|
| Monolayer-based direct differentiation | Late stage (about 100 days) cells exhibit |
| organized, longer sarcomeres with aligned Z-disks and organized A- and I-bands | ||
| Dense and aligned myofibrils | ||
| Higher degree of multinucleation | ||
| MYH6 and MYH7 expression level comparable to adult human heart | ||
| Improved contraction, Ca2+ handling and AP characteristics | ||
|
| Suspension EB | Allele-specific RNA interference can rescue diseased phenotype in LQTS cardiomyocytes |
|
| Suspension EB | Cx43 mediates the expression of genes involved in cardiogenesis |
|
| Hanging-drop EB | Three-dimensional culture and cardiac fibroblast co-culture improved sarcomere organization and Cx43 expression |
|
| Suspension EB and monolayer-based direct differentiation | Three-dimensional culture increased the expression level of TNNT2 |
|
| Suspension EB, | Sparse, irregularly distributed Cx43 expression |
| END-2 co-culture | ||
|
| Directed differentiation (suspension EB) | Expression level of structural proteins are lower than in fetal ventricular CMs |
| Purified ventricular phenotype | ||
|
| Suspension EB, dissected CMs | Electrophysiological characterization over a 3-month period |
| Maturation approaching an adult phenotype | ||
|
| Suspension EB | iPSC-derived engineered cardiac tissue |
| Combination of a matrix-based microenvironment, uniaxial mechanical stress and a mixture of cells improved engineered cardiac tissue performance | ||
|
| Suspension EB | Expression of cardiac genes approached levels in adult LV myocardium in engineered cardiac tissues |
|
| Suspension EB | Functional integration into myocardium |
| Cell-based pacemaker | ||
|
| Suspension EB | Well-developed sarcomeric structures found in three-dimensional cardiac patches |
| Upregulated E-C coupling and contractile genes | ||
|
| Suspension EB | Sparse, irregularly distributed Cx43 expression |
AP, action potential; CM, cardiomyocyte; Cx43, connexin 43; EB, embryoid body; E-C, excitation-contraction; hESC, human embryonic stem cell; hESC-CM, human embryonic stem cell-derived cardiomyocyte; hiPSC, human induced pluripotent stem cell; iPSC, induced pluripotent stem cell; LQTS, long QT syndrome; LV, left ventricular; NRVM, neonatal rat ventricular myocyte; TNNT2, cardiac troponin T.
Effects of external factors on maturation
| External factors | Effects on developmental maturation | Reference |
|---|---|---|
|
| Affects differentiation efficiencies. Intermediate-stiffness hydrogels lead to the highest efficiencies | Hazeltine |
|
| Increases organization of sarcomeric myofilaments | Ou |
| Zhang | ||
| Increases cardiac gene expression | Pal | |
| Turnbull | ||
| Increases contractile and Ca2+ handling protein expression | Tulloch | |
| Zhang | ||
| Promotes alignment and anisotropy | Liau | |
| Promotes functional maturation in general | Christoforou | |
| Two-dimensional alignment and groove widths between 30 and 80 μm promote alignment and improve sarcomere structures | Salick | |
|
| Increases expression of cardiac α-actin and MYH6, and enhances expression of cardiac transcription factors | Gwak |
| Improves tissue morphology and enhances active force levels | Kensah | |
| Increases cell alignment | Tulloch | |
| Schaaf | ||
| Thavandiran | ||
| Zhang | ||
| Increases proliferation rates | Tulloch | |
| Increases AP duration and upstroke velocity, but leads to a less negative MDP | Schaaf | |
| Increases cell size, cytoskeletal assembly and sarcomeric organization | Foldes | |
| Cyclic stretch improves TNNT2 and Cx43 expression, increases contraction rates and shortens calcium transients | Mihic | |
|
| Leads to better structured and organized myofilaments | Lieu |
| Produces cell elongation, affects expression of a group of cardiac-related genes | Chan | |
| Chen | ||
| Improves cardiomyocyte alignment, cross-striation patterns and force development | Hirt | |
|
| Elicits ARVD/C phenotype of increased apoptosis, elevated lipogenesis, and impaired calcium handling in | Kim |
| Galactose and fatty acids increase oxidative phosphorylation levels, reserve capacity, and maximum respiratory capacity in mitochondria | Rana | |
| Glucose depletion along with lactose supplementation increase cardiomyocyte purity | Tohyama | |
| Induction of mitochondrial biogenesis increases cardiomyocyte differentiation | Prowse | |
|
| Stimulating p38-MAPK increases cell size, improves sarcomere and cytoskeletal assembly | Foldes |
| Heineke and Molkentin 2006 [ | ||
| Thyroid hormone increases cardiomyocyte size, sarcomere length, contractile force and anisotropy | Yang | |
| Adrenergic agonists produce hypertrophy | Foldes | |
| IGF1 together with electrical or electromechanical stimulation improve NRVM engineered tissue function, SERCA2a and TNNT2 expression | Park | |
| Morgan and Black 2014 [ |
AP, action potential; ARVD/C, arrhythmogenic right ventricular dysplasia/cardiomyopathy; Cx43, connexin 43; IGF-1, insulin-like growth factor 1; MAPK, mitogen-activated protein kinase; MDP, maximal diastolic potential; NRVM, neonatal rat ventricular myocyte; TNNT2, cardiac troponin T.
Figure 3Optical characterization of hPSC-CM electrophysiology. Optical mapping of enzymatically digested and re-plated human induced pluripotent stem cell-derived cardiomyocyte monolayers recorded 9 days (A-C) and 13 days (D-F) after re-plating. (A) Transmembrane voltage map of 9-day re-plated monolayer. (B) Activation time map and local conduction velocity vectors of (A). (C) Action potential recorded from location indicated by white box in (A). Electrical coupling among the cells of this 9-day old monolayer is poor, as indicated by the disorganized activation time map, rough wavefront of the propagating AP and slow conduction velocity (5.4 cm/second). (D) Transmembrane voltage map of a 13-day re-plated monolayer. (E) Activation time map and local conduction velocity vectors of (D). (F) Action potential recorded from location indicated by white box in (D). Electrical coupling was much improved with increased time in culture, as indicated by the near planar propagating action potential as well as faster conduction velocity (10.5 cm/second). Dashed lines in (C) and (F) indicate the time points of the corresponding transmembrane voltage maps in (A) and (D).